Phillips shares fell sharply Wednesday as the Food and Drug Administration said there’s an emerging safety issue involving its product for sleep apnea.
The FDA said the issue is with the DreamStation 2 Continuous Positive Airway Pressure machines used for treatment of obstructive sleep apnea. The FDA said there are medical device reports showing “fire, smoke, burns and other signs of overheating while using the machine.”
The…
Master your money.
Subscribe to MarketWatch.
Get this article and all of MarketWatch.
Access from any device. Anywhere. Anytime.
Subscribe Now
Already a subscriber?
Log In
Read the full article here
